Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.86 AED | 0.00% | +0.70% | -3.70% |
Apr. 11 | UAE's ADNOC recently eyed BP as takeover target, sources say | RE |
Apr. 04 | Adnoc's Acquisition of Fertiglobe Gets EU Clearance | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company returns high margins, thereby supporting business profitability.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.70% | 6.46B | - | ||
-16.21% | 14.7B | D+ | ||
+0.11% | 14.94B | B+ | ||
+3.51% | 12.24B | C | ||
-14.72% | 9.8B | B+ | ||
-.--% | 7.17B | - | C- | |
-10.40% | 3.95B | B- | ||
-25.53% | 2.48B | D | ||
+1.67% | 2.01B | - | ||
-7.99% | 1.88B | - | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- FERTIGLB Stock
- Ratings Fertiglobe plc